Healthcare provider profile · identity verified

Jon L Simmons, MD

Family Practice · MARINETTE, WI · NPI 1336189075

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1162	303
Lisinopril	Lisinopril	666	171
Amlodipine Besylate	Amlodipine Besylate	584	149
Rosuvastatin Calcium	Rosuvastatin Calcium	453	126
Omeprazole	Omeprazole	441	119
Levothyroxine Sodium	Levothyroxine Sodium	386	86
Losartan Potassium	Losartan Potassium	362	90
Tamsulosin Hcl	Tamsulosin Hcl	330	87
Metoprolol Succinate	Metoprolol Succinate	315	81
Pantoprazole Sodium	Pantoprazole Sodium	313	85
Furosemide	Furosemide	278	78
Metoprolol Tartrate	Metoprolol Tartrate	243	67
Metformin Hcl	Metformin Hcl	232	57
Metformin Hcl Er	Metformin Hcl	218	54
Simvastatin	Simvastatin	206	48
Albuterol Sulfate Hfa	Albuterol Sulfate	202	77
Allopurinol	Allopurinol	198	44
Gabapentin	Gabapentin	194	43
Potassium Chloride	Potassium Chloride	193	55
Hydrochlorothiazide	Hydrochlorothiazide	188	55
Sertraline Hcl	Sertraline Hcl	172	43
Fluticasone Propionate	Fluticasone Propionate	155	66
Eliquis	Apixaban	153	38
Clopidogrel	Clopidogrel Bisulfate	132	34
Ozempic	Semaglutide	132	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	31
Pravastatin Sodium	Pravastatin Sodium	123	32
Trazodone Hcl	Trazodone Hcl	122	30
Carvedilol	Carvedilol	113	28
Prednisone	Prednisone	92	36
Atenolol	Atenolol	89	22
Duloxetine Hcl	Duloxetine Hcl	89	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	87	23
Lorazepam	Lorazepam	85	21
Famotidine	Famotidine	83	28
Warfarin Sodium	Warfarin Sodium	81	22
Finasteride	Finasteride	80	19
Fluoxetine Hcl	Fluoxetine Hcl	79	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	21
Spironolactone	Spironolactone	73	18
Glipizide Er	Glipizide	71	17
Irbesartan	Irbesartan	71	20
Glipizide	Glipizide	70	21
Torsemide	Torsemide	66	13
Triamcinolone Acetonide	Triamcinolone Acetonide	65	32
Trulicity	Dulaglutide	64	11
Jardiance	Empagliflozin	63	15
Valsartan	Valsartan	61	15
Meloxicam	Meloxicam	60	17
Xarelto	Rivaroxaban	60	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	14
Mirtazapine	Mirtazapine	57	12
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Montelukast Sodium	Montelukast Sodium	49	13
Naproxen	Naproxen	49	23
Tramadol Hcl	Tramadol Hcl	49	15
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Enalapril Maleate	Enalapril Maleate	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Pregabalin	Pregabalin	44	suppressed
Fenofibrate	Fenofibrate	43	suppressed
Alprazolam	Alprazolam	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Mounjaro	Tirzepatide	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Ezetimibe	Ezetimibe	40	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	31
Klor-Con M20	Potassium Chloride	39	13
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Glimepiride	Glimepiride	37	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Azelastine Hcl	Azelastine Hcl	34	11
Novolog Flexpen	Insulin Aspart	34	suppressed
Cephalexin	Cephalexin	32	21
Doxycycline Hyclate	Doxycycline Hyclate	30	26
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Fenofibrate	Fenofibrate,micronized	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Nystatin	Nystatin	24	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Baclofen	Baclofen	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Nitroglycerin	Nitroglycerin	20	17
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Metolazone	Metolazone	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Ketoconazole	Ketoconazole	16	12
Ondansetron Odt	Ondansetron	16	suppressed
Potassium Citrate Er	Potassium Citrate	16	suppressed
Ramipril	Ramipril	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Epinephrine	Epinephrine	14	13
Gemfibrozil	Gemfibrozil	14	suppressed
Klor-Con M15	Potassium Chloride	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error